Patient Recruitment A Focus of DIA 2016

ATLANTA, GA – July 20, 2016: Bethany Bray, Chief Executive Officer and Co-Founder of AutoCruitment recently presented at the DIA Annual Meeting in Philadelphia in June. Drug Information Association (DIA) is the only global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide and has become an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.

The session entitled “Patient Recruitment in Rare Diseases: Ideas and Framework for out-of-the-Box Exploration”, explored the challenges of recruiting patient participants in clinical studies involving rare diseases where populations are small and geographically dispersed. The aim of the session was to “catalyze unconventional thinking and to provide a framework to organize innovative recruitment ideas.” The discussion focused on patient recruitment, retention, engagement and clinical trial designs.

Bethany’s presentation, “Direct-to-Patient Digital Recruitment: A Targeted Approach to Recruitment Enrollment and Retention”, addressed how targeted digital marketing techniques can be used to target, engage and recruit the right patients in the external patient population; improving recruitment, enrollment and retention problems in clinical trials. An Oncology and Neuroscience Researcher, Entrepreneur and Technologist, Bethany founded AutoCruitment to fulfill a vision of utilizing the power of the internet to address recruitment, enrollment and retention problems in clinical trials.

“It was an honor to be asked to speak at DIA. As a company we were impressed with the number of sessions that discussed how Sponsors and CROs approach patient recruitment, highlighting that typically Sponsors and CROs will rely solely on research sites or key opinion leaders (KOLs) to recruit patients from existing databases, which creates a bottleneck. We couldn't agree more.” comments Bray.  “There is a need to devise strategies to reach out to patients in the external community directly. A targeted digital recruitment strategy allows us to attract the right patients in the external community, screen them online and automatically and immediately refer them to the KOLs or contracted research sites; removing the bottleneck and ultimately accelerating the trial timeline.”

AutoCruitment is able to provide a path to effective digital marketing presence through a proprietary and targeted, direct-to-patient, online marketing platform that targets, recruits, screens and automatically refers new patients for clinical trials or specialty medical procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers.

“DIA was an excellent opportunity for AutoCruitment to highlight the innovative strategies that we are employing to accelerate patient recruitment.  Getting the buy-in from CROs and Sponsors is incredibly important in adopting new digital technologies to improve not just patient recruitment but the overall outcome of the clinical trial or specialty study.”

To learn more about how AutoCruitment can develop unique strategies to support your clinical trials, contact Bethany Bray directly at Bethanybray@autocruitment.com. 

AutoCruitment Co-Founder & CEO Bethany Bray To Present and Participate in a Panel At DIA Annual Meeting

ATLANTA, GA – June 23, 2016: Bethany Bray, Chief Executive Officer and Co-Founder of AutoCruitment will be a featured presenter and panelist at the DIA Annual Meeting in Philadelphia in June. Drug Information Association (DIA) is the only global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide and has become an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.

The session entitled “Patient Recruitment in Rare Diseases: Ideas and Framework for out-of-the-Box Exploration”, will explore the challenges of recruiting patient participants in clinical studies involving rare diseases where populations are small and geographically dispersed. The aim of the session is to “catalyze unconventional thinking, judge industry leaders various recruitment strategies and to provide a framework to organize innovative recruitment ideas.” The discussion will focus on patient recruitment, retention, engagement and clinical trial designs.

Bethany’s initial presentation, “Direct-to-Patient Digital Recruitment: A Targeted Approach to Recruitment Enrollment and Retention”, addresses how digital marketing techniques can be used to recruit, control and retain enrolled participants in clinical trials. An Oncology and Neuroscience Researcher, Entrepreneur and Technologist, Bethany founded AutoCruitment to fulfill a vision of utilizing the power of the internet to address recruitment, enrollment and retention problems in clinical trials.

AutoCruitment is able to provide a path to effective digital marketing presence through a proprietary and targeted, direct-to-patient, online marketing platform that targets, recruits, screens and automatically refers new patients for clinical trials or specialty medical procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers.

Bray has 10 years of experience in Pharmaceutical Research, Operations and Business Development and holds a BSc in Pharmacology, a Masters in Translational Medicine & Neuroscience from Imperial College London and an MBA from the Georgia Institute of Technology.

For more information on the DIA 2016 Annual Meeting and Conference and how you can participate click on http://www.diaglobal.org/.

 

About AutoCruitment

Originally formed in 2013 as NeuroCruitment with a sole focus on neurological diseases and recruitment for clinical trials, the benefits and effectiveness of the company’s unique web-based software platform quickly attracted CROs, sponsors and research sites addressing other therapeutic areas as well as Hospitals, Cancer Centers and Physicians groups looking to increase revenues through new patient referrals for specialty procedures. The company changed its name in early 2015 to AutoCruitment and expanded its offering; referring patients for both clinical trials and specialty procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers. Clients are not the only ones to benefit from expediting the recruiting process; the platform empowers people who are suffering from chronic illness or disease with the ability to locate specialist providers and/or enroll in applicable clinical trials that offer access to potentially life-changing medical advances.

For more information contact AutoCruitment at info@autocruitment.com

Digital Marketing Is Critical for Pharmaceutical Companies, CROs and Healthcare Providers to Engage and Retain Patients for Clinical Trials.

"If I were diagnosed with something tomorrow, one of the first things I would do is go online."

Digital marketing, the use of internet based media activities like content marketing, e-commerce, social media, e-mail direct, digital display advertising, search engine advertising and the use of video imagery across digital media like mobile phones, smart devices and laptops has become the preferred method to connect product and service providers with customers. The era of television, radio and traditional print mass media’s dominance is being upended, as digital savvy consumers are demanding more information from providers in a more individualized relationship. Digital marketing is causing a shift from a marketer empowered mass distributed connection to a consumer empowered, individualized personal relationship connection.

As with many industries, the delivery of healthcare has been dramatically disrupted by the digital technology revolution, both in the way services are provided and how the health care industry markets to their consumers.  Accustomed to traditional institutional forms of marketing, the Pharmaceutical and Healthcare sectors tasked with transitioning to the new digital communication environment are finding it challenging but critical in order to remain competitive especially in clinical trial patient recruitment.

Bethany Bray, Founder & CEO, AutoCruitment says, "In order for Pharmaceutical Companies or healthcare providers to actively engage and reach potential patients, it's critical to develop a marketing strategy that accounts for digital marketing.  We often see clients engage our firm in rescue mode, after most of the marketing budget has been spent, resulting in an anemic digital marketing effort. With more than 80 percent of consumers utilizing the internet to look up health related information it is imperative to invest in a marketing strategy that promises the most lucrative return on investment.” Many health-care marketing professionals say digital's measurability helps them defend their budgets. "Return on investment is on the top of everybody's agenda," said Paul Matsen, CMO of Cleveland Clinic.

Pharmaceutical Companies, CROs and healthcare providers conducting clinical trials are facing a brand new world of transparency and competition brought on by technology. Just as other industries have been compelled to abandon well established methods of attracting customers and promoting their services, Pharmaceutical Companies, CROs and healthcare providers must embrace the digital marketing experience to engage an ever more informed patient. "The patient journey is largely a digital journey at their moment of need," said John Weston, CMO at Mayo Clinic. "If I were diagnosed with something tomorrow, one of the first things I would do is go online."

AutoCruitment provides a path to effective digital marketing presence through a proprietary and targeted, direct-to-patient, online marketing platform that targets, recruits screens and automatically refers new patients for clinical trials or specialty medical procedures. By streamlining the patient recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers.

For more information contact AutoCruitment at info@autocruitment.com